PMID: 7528766Jan 1, 1995Paper

Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein

The Journal of Experimental Medicine
Y U KimV Michael Holers

Abstract

Normal host cells are protected from the destructive action of complement by cell surface complement regulatory proteins. In humans, decay-accelerating factor (DAF) and membrane cofactor protein (MCP) play such a biologic role by inhibiting C3 and C5 convertases. DAF and MCP accomplish this task by specific mechanisms designated decay-accelerating activity and factor I cofactor activity, respectively. In other species, including mice, structural and/or functional homologues of these proteins are not yet well characterized. Previous studies have shown that the mouse protein Crry/p65 has certain characteristics of self-protecting complement regulatory proteins. For example, Crry/p65 is expressed on a wide variety of murine cells, and when expressed on human K562 erythroleukemic cells, it prevents deposition of mouse C3 fragments on the cell surface during activation of either the classical or alternative complement pathway. We have now studied factor I cofactor and decay-accelerating activities of Crry/p65. Recombinant Crry/p65 demonstrates cofactor activity for factor I-mediated cleavage of both mouse C3b and C4b. Surprisingly, Crry/p65 also exhibits decay-accelerating activity for the classical pathway C3 convertase strongly an...Continue Reading

References

Feb 28, 1978·Biochemical and Biophysical Research Communications·P J Fraker, J C Speck
Sep 1, 1992·Baillière's Clinical Obstetrics and Gynaecology·C H Holmes, K L Simpson
Dec 1, 1991·The Journal of Experimental Medicine·K R KalliD T Fearon
Jan 1, 1989·Annual Review of Immunology·D M Lublin, J P Atkinson
Apr 1, 1989·The Journal of Experimental Medicine·S F KingsmoreM F Seldin
Dec 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·M D MooreG R Nemerow
Jan 1, 1994·Springer Seminars in Immunopathology·B P Morgan, S Meri
Jan 27, 1994·The New England Journal of Medicine·T MiyataT Kinoshita
Jun 1, 1993·European Journal of Immunology·S FoleyV M Holers

❮ Previous
Next ❯

Citations

Dec 23, 2004·Springer Seminars in Immunopathology·V Michael Holers
Dec 11, 2008·Clinical Reviews in Allergy & Immunology·Ingrid Avalos, George C Tsokos
Oct 6, 2007·Immunologic Research·Brian K Martin
Apr 26, 2013·Immunologic Research·Eleonora BallantiRoberto Perricone
Aug 14, 2003·Molecular Immunology·Daniel Turnberg, Marina Botto
Mar 4, 2000·Molecular Immunology·S M Linton, B P Morgan
Jul 25, 2000·Immunopharmacology·V M Holers
Jun 5, 2003·Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology·Yukio YokotaKeisuke Yamano
Sep 12, 2002·Trends in Molecular Medicine·Richard J Quigg
Jul 27, 1999·The Biochemical Journal·C L HarrisB P Morgan
May 1, 1997·Immunology·Y KawamotoA Miyama
Nov 21, 1998·Immunology·K NishikawaH Okada
Aug 14, 1999·Immunology·O B SpillerB P Morgan
Sep 5, 2001·Kidney International·P N CunninghamR J Quigg
Oct 27, 2010·Proceedings of the National Academy of Sciences of the United States of America·Xiaobo WuJohn P Atkinson
Jan 6, 2012·Proceedings of the National Academy of Sciences of the United States of America·Valeria RamagliaB Paul Morgan
Oct 9, 1998·The Journal of Experimental Medicine·B SchillerR J Quigg
Jan 24, 2002·The Journal of Experimental Medicine·V Michael HolersJane E Salmon
Aug 23, 2006·The Journal of Experimental Medicine·Guillermina GirardiJane E Salmon
Aug 23, 2002·Current Opinion in Rheumatology·Hector Molina
Jul 29, 2011·Acta Crystallographica. Section F, Structural Biology and Crystallization Communications·Pietro RoversiSusan M Lea
Sep 19, 2002·Protein Science : a Publication of the Protein Society·Deborah A FraserB Paul Morgan
Apr 16, 2005·Clinical Microbiology Reviews·Alain L Servin
Sep 23, 2003·American Journal of Respiratory and Critical Care Medicine·Christian TaubeErwin W Gelfand
Jan 1, 2004·American Journal of Respiratory and Critical Care Medicine·Jung-Won ParkErwin W Gelfand
Oct 14, 2010·The Journal of Clinical Investigation·Yuko KimuraWen-Chao Song
Nov 18, 2009·Journal of Neuroinflammation·Julia ReichwaldMatthias Staufenbiel
Mar 19, 2014·PloS One·Lee Daniel ChavesRichard John Quigg
Dec 4, 2012·International Journal of Molecular Sciences·Wajih BukhariSimon A Broadley

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alternative Complement Pathway

The Alternative Complement Pathway is part of the innate immune system, and activation generates membrane attack complexes that kill pathogenic cells. Discover the latest research on the Alternative Complement Pathway.